Snowden Capital Advisors LLC Ligand Pharmaceuticals Inc Transaction History

Snowden Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $4,939 - $7,881	-52 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $6,639 - $8,624	52 New	52 $8,000
Q3 2019 Jan 08, 2024	SELL	$86.25 - $120.16 $983,250 - $1.37 Million	-11,400 Closed	0 $0
Q2 2019 Jan 08, 2024	BUY	$107.38 - $129.34 $1.22 Million - $1.47 Million	11,400 New	11,400 $6.17 Million

256

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.84B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.